The glycogenolytic and hypertensive effect of physostigmine in the anti-nerve-growth-factor-serum-treated rats.
Varagić, V M
The glycogenolytic and hypertensive effect of physostigmine in the anti-nerve-growth-factor-serum-treated rats. [electronic resource] - European journal of pharmacology Oct 1970 - 194-202 p. digital
Publication Type: Journal Article
0014-2999
10.1016/0014-2999(70)90065-8 doi
Animals
Blood Pressure--drug effects
Brain Chemistry
Cerebellum--analysis
Cerebral Cortex--analysis
Diaphragm--drug effects
Female
Ganglia, Autonomic--drug effects
Glycogen--analysis
Growth Inhibitors
Hypothalamus--analysis
Liver--drug effects
Liver Glycogen--analysis
Male
Medulla Oblongata--analysis
Mesencephalon--drug effects
Myocardium--analysis
Nerve Growth Factors--antagonists & inhibitors
Nerve Tissue--drug effects
Neurons--drug effects
Organ Size
Physostigmine--pharmacology
Rats
The glycogenolytic and hypertensive effect of physostigmine in the anti-nerve-growth-factor-serum-treated rats. [electronic resource] - European journal of pharmacology Oct 1970 - 194-202 p. digital
Publication Type: Journal Article
0014-2999
10.1016/0014-2999(70)90065-8 doi
Animals
Blood Pressure--drug effects
Brain Chemistry
Cerebellum--analysis
Cerebral Cortex--analysis
Diaphragm--drug effects
Female
Ganglia, Autonomic--drug effects
Glycogen--analysis
Growth Inhibitors
Hypothalamus--analysis
Liver--drug effects
Liver Glycogen--analysis
Male
Medulla Oblongata--analysis
Mesencephalon--drug effects
Myocardium--analysis
Nerve Growth Factors--antagonists & inhibitors
Nerve Tissue--drug effects
Neurons--drug effects
Organ Size
Physostigmine--pharmacology
Rats